University Medical Center, Hamburg Eppendorf

Hamburg D-20246

8 studies enrolling now · 32 studies all time

What they study most

Acute Leukemia (Category), Acute-On-Chronic Liver Failure, Aneurysm of Aorta, Thoracic, Aneurysmal Disease, Aorta, Thoracic Pathologies, Aortic Aneurysm, Aortic Aneurysm and Dissection, Aortic Diseases, Atherosclerosis, Barrett Adenocarcinoma, Barrett Esophagus, Canavan Disease

Studies at this site

• A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta — Recruiting now
• Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer — Recruiting now
• A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD — Recruiting now
• SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma — Recruiting now
• Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs — Recruiting now
• Enhanced Valves Interventions and Safe AI Generated End Results — Recruiting now
• Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow — Running, not enrolling
• Fragility Fractures of the Pelvis (FFP) — Running, not enrolling
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB) — Starting soon
• Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors — Running, not enrolling
• Pegcetacoplan Long Term Safety and Efficacy Extension Study — Completed
• Natural History Study of Patients With Canavan Disease (CANinform Study) — Completed
• Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR) — Completed
• IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact — Running, not enrolling
• Posterior cerebraL ArTery Occlusion Study — Completed
• Safety, Tolerability and Efficacy of ICV AX 250 Treatment in MPS IIIB -OLE — Enrolling by invitation
• Neoplastic Barrett Esophagus: Endoscopic Piecemeal vs. En Bloc Resection — Status unconfirmed
• A Treatment Extension Study of Mucopolysaccharidosis Type IIIB — Status unconfirmed
• A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB) — Status unconfirmed
• A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients — Completed
• Study of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA) — Status unconfirmed
• Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia — Stopped early
• A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures — Completed
• Insulin Resistance Intervention After Stroke Trial — Completed
• A Natural History Study of Canavan Disease — Completed
• Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia — Status unconfirmed
• Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) — Completed
• Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF — Completed
• Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia — Completed
• Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis — Completed
• Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM) — Completed